About Lennham Pharmaceuticals
Lennham Pharmaceuticals is a private company based in Concord, Massachusetts, incorporated in 2019 in Delaware. It has reported $3,525,000 raised in two offerings on Form D since March 2021. Its chief executive is Bradford Sippy.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 28, 2021 | Apr 4, 2023 | $1,200,000fully sold | 13 | $92,308 | DebtRule 506(b) | Form D ↗ |
| Oct 19, 2019 | Mar 25, 2021 | $2,325,000fully sold | 19 | $122K | DebtRule 506(b) | Form D ↗ |
| Total, two offerings | $3,525,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Lennham Pharmaceuticals's Form D filed Apr 4, 2023.
BE
Benjamin Enerson
Executive officer
BS
Bradford Sippy
CEO and director
CM
Corey MacGregor
Executive officer